Larissa Karnaoukhova, Ph.D, MBA

760-***-**** ? abk0ln@r.postjobfree.com

Life Science professional with product development, management, sales and

marketing experience.

MDx business Project management Customer relations

development

CRO sales Market research Licensing agreements

Tissue culture Life Sciences market analytics Strategy development

RT-PCR cDNA cloning and sequencing High throughput gene

cloning

Marketing Experience

Life Technologies, MBA Fellow-Internship

2009

Gathered market analytics in support of strategic planning for Cell Systems

Division

. Performed market analysis and segmentation for individual product lines

to identify key market trends and drivers

. Performed customer analysis and segmentation to identify unmet customer

needs, workflow analysis and potential new product opportunities

. Analyzed competitive landscape of specific markets to identify areas of

potential growth

. Created a knowledge database for market analytics analysis

. Performed financial analysis of sales per product line and per customer

using Cognos database.

VC Firm, Independent Study Consultant

2008-2009

Developed market repositioning and value proposition for a hormone

replacement therapy

. Evaluated commercial potential for an existing skin patch therapy

. Designed on-line surveys and conducted OBGYN physician and patient

interviews

. Provided recommendations for target market segmentation and product

positioning statement

Confirm BioSciences, Independent Study Consultant

2008-2009

Performed market validation and business case analysis for an expansion of

in-home drug testing products into national retail pharmacy chains

. Conducted primary market research, focus groups and on-line surveys

. Performed market segmentation and SWOT analysis

. Provided recommendations for marketing communications plan and cost

analysis

. Developed financial model to assess the viability and ROI for the

project

. Analyzed firm exit opportunities and provided recommendation of

potential acquirer companies

The Nicholas Conor Institute, Independent Study Consultant

2008-2009

Developed business plan for a non-profit institute for pediatric cancer

research

. Analyzed disease management value chain and identified market

opportunities for disease-specific molecular diagnostic tests.

Performed industry scenarios and risk mitigation analysis.

. Proposed a collaborative framework of academic researchers, industry

leaders and clinicians in developing new diagnostic tests and therapies

for pediatric oncology patients

. Designed philanthropist survey to help identify fund raising strategies

BUSINESS DEVELOPMENT AND SALES EXPERIENCE

Gene Express Inc, West Coast Business Development Manager

2007-2008

Emerging molecular diagnostics company with a proprietary PCR-based gene

expression technology and IP around quality control and standardization of

gene expression data

. Contributed to the new strategy development and execution

. Prospected customers for product sales, services agreements, and

licensing deals

. Developed sales plan targeting CROs, clinical reference labs, biotech

and pharmaceutical companies, and academic research organizations.

Visited and organized meetings with executive teams, promoted company

at industry meetings and conferences

. Participated in FDA (510)k IVDMIA submission of a lung cancer risk

assessment test

. Managed relationship with a CLIA certified clinical reference

laboratory that resulted in agreements covering licensing and

commercialization of molecular diagnostic tests.

. Negotiated Strategic Alliance Agreement with a major life science

company leading to product licensing and test commercialization

agreements

VWR International, VWR BioSciences Sales Manager, Southern California

2006-2007

Business development and marketing arm of a diverse set of global contract

research organizations (CROs) that provided drug discovery and development

services in established (US, Europe) and emerging (India, Russia) markets.

Clients included Gene Express Inc, Visual Sonics, Battelle CRO, GenScript,

Vybion, Dalton Pharma, Alphalyse, Proteros, MIR, Cardinal Clinical,

Cureline, Tecan, Neoclone, BioGenes, ZeptoMetrix.

. Developed new territory and customer base in Southern California,

Arizona, and Colorado.

. Engaged customers at various stages of drug development process

including high throughput cloning and gene expression, immunological

and virology testing, disease specimen collection and storage, pre-

clinical, formulation and analytical services, sterile fill, API

manufacturing, small molecule and peptide synthesis, sequencing,

protein analysis, protein crystal structures, microarrays, antibody

development, in-vivo animal imaging, cancer models and pharmacology

services, clinical trials, and tissue procurement among others

. Initiated and facilitated a deal for Proteros with a San Diego-based

biotech company

. Identified new ad-hoc service provider to meet customer need for cGMP-

compliant mammalian cell protein production and manufacturing

capability

R&D PRODUCT DEVELOPMENT AND MANAGEMENT EXPERIENCE

The Dow Chemical Company, DowPharma, San Diego, CA

2006

Bioinformatics Specialist

Completed a project to update Vector NTI database utilized internally and

for client report submissions.

. Designed a framework to update plasmid sequences propagated in

Pseudomonas fluorescens as part of Pfenex protein expression

technology.

. Improved the quality, accuracy and speed of vector map submission.

. Trained users on the software features and applications.

Life Technologies Invitrogen Corporation, Carlsbad, CA

1998 - 2006

Sr. Scientist/Technical Area Manager, Clone Collections

2004 - 2006

Led a team of Research Scientists focused on building human Ultimate ORF

clone collection, a high throughput gene cloning and sequencing project.

* Organized and directed multi-site cross-functional team that developed

strategy for the collection build. Doubled pipeline productivity

resulting in 72% growth of the collection.

* Negotiated service contract with outside sequencing vendor that reduced

cost per clone by 50%.

* Designed and successfully integrated alternative high throughput cloning

methods that enriched content and added value to the collection.

* Optimized operations achieving 20% pass rate increase which translated

into $330K cost savings.

* Led team through effective team building exercise which improved

interaction and productivity.

Research Scientist

2000 - 2004

Managed multiple product and services development projects; researched

customer needs and product opportunities; developed and optimized protocols

and quality control; led cross-site cross-functional new product

introduction (NPI) teams.

* Developed CloneMiner cDNA library construction kit, a pioneer method for

cloning and expression of full-length genes.

* Developed GeneRacer RACE-ready cDNA kits, a unique source of ready-to-use

cDNA for identification and expression of novel full-length genes from

various tissues.

* Coordinated and contributed to development of novel DNA and RNA

purification methods.

* Published product reviews and presented products at scientific meetings

and exhibit showcases.

* Recognized for exceptional level of quality customer technical support.

Post-doctoral Scientist

1998 - 2000

Developed a full-length gene cloning and sequencing kit.

* Developed GeneRacer kit, a first to market product utilizing most

advanced technology for amplification and identification of full-length

cDNA ends.

* Served as R&D lead in cross-functional New Product Introduction team

resulting in manufacturing transfer and successful market launch of the

kit.

SCIENTIFIC RESEARCH

University of Victoria, BC, Canada, Research Associate, 1992-1998

. Quantified, sequenced and characterized hprt mutations produced in vivo

by chemotherapy in peripheral blood T-lymphocytes of cancer patients

. Developed and optimized FISH assay to detect specific chromosomal

rearrangement induced by chemotherapy in peripheral blood T-lymphocytes

of cancer patients

EDUCATION

MBA, Marketing and Finance, UCSD, Rady School of Management, 2009

Ph.D, Molecular Biology, University of Victoria, Victoria British Columbia,

Canada, 1998

. Dissertation: "Genotoxic effects in cancer patients after treatment

with single drug etoposide or melphalan chemotherapy"

M.Sc, Physics, Moscow State University, Moscow, Russia, 1992

. Thesis: Electron transfer reactions in Rb.Sphaeroides chromatophores on

colloidal membrane

PROFESSIONAL TRAINING

Customer Centric Selling, Managing for Results Leadership Course, Lean and

Six Sigma

Languages and Computer Skills

Bilingual: English, Russian

MS Office, Excel, SeqMan, Vector NTI, Salesforce, LotusNotes, Cognos, Pivot

Tables

Contact this candidate